Please login to the form below

Not currently logged in

The PT Marketer of the Year competition due to close this Friday

Enter directly or nominate a colleague or team member

PT Marketer

Celebrating its 25th anniversary, the free-to-enter PharmaTimes Marketer of the Year Competition is closing for entries in just two days.

Designed to both assess and reward the competencies and potential of pharma marketers, the awards identifies and benchmarks marketing talent within pharma organisations against the wider industry.

Finalists are not judged on past work, but will be evaluated based on their performance during a head-to-head real life challenge against their peers.

Those who take part will receive qualitative and quantitative judges’ feedback.

Sabina Syed, managing director at Visions4Health and co-chair of the Marketer of the Year executive steering group, said: “This is the only competition that supports professional development and independently tests candidates on their marketing and communication skills against their peers across the industry.”

There are a total of six categories to choose from, including Market Access Lead of the Year, New Marketer of the Year, and new for 2018, the Aspiring Business Unit/Marketing Director.

Previous winner in the New Marketer of the Year Category Thom Renwick, Sales manager at Roche, said: “This type of experience not only helps you to benchmark but also allows you to network with some of the brightest minds in pharma.”

The programme accepts both nominations and direct entry and winners will be announced on Thursday 15 November at The Tower Hotel in London, alongside the PharmaTimes Sales Awards and Communications Team of the Year

Article by
Gemma Jones

11th September 2018

From: Marketing


Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...